Product Details
trace blood technology blood glucose meter kit for pharmacy
SAFE-AQ VOICE
BLOOD GLUCOSE MONITORIG SYSTEM
SPECIFICATION
FAD-GDH System
Blood sample:fresh capillary whole blood, venous whole blood
Calibration sample:venous plasma
Test range:20-600mg/dL(1.1-33.3mmol/L)
Test time:5s
Blood volume:0.6ul
HCT:30-60%
Expiry date:24 months
Memory:10 test results
Battery lifetime:above 1000 times
In the sales and market aspect, through the realization of terminal
coverage, channel coverage and product coverage strategy, enhance
the company industry scale, improve market share, forming a
complete product structure, strengthen its leading position in the
industry. Improve the technical level and innovation mode of
existing products and services, consolidate the leading position of
the company in the industry, and build a sustained and stable
profitability.
Company Profile
Sinocare is a high-tech enterprise dedicated to the development,
production and sales of the rapid detection of chronic diseases in
the use of bio sensing technology. Since its inception in 2002, has
been adhering to the business purpose “Honor Commitment Dedicate to
Healthcare", focus on promoting the development of diabetes health.
Sinocare is a high-tech enterprise dedicated to the development,
production and sales of the rapid detection of chronic diseases in
the use of bio sensing technology. Since its inception in 2002, has
been adhering to the business purpose “Honor Commitment Dedicate to
Healthcare", focus on promoting the development of diabetes health.
Sinocare as a national high-tech industrialization demonstration
project, has won National Innovation Fund support, and took the
lead through the ISO 13485 Quality Management System certification
and the CE certification of EU. The SANNUO series blood glucose
meter and a test strips, with the characteristics of the "accuracy,
simple and economic", recognized by the vast number of consumers,
the "Sinocare" trademark was identified as "China well known
trademark by State Administration of industry and Commerce of. The
products are not only popular in China, but also in the
international market. In March 19, 2012, the company listed on the
Shenzhen stock exchange gem, as the first Bio sensor stock in
China. In 2015, the blood glucose meter in the domestic retail
market share reached 51%, becoming the industry leader in blood
glucose monitoring products, the same year was elected to the
Forbes Asian small and medium companies top 200 list. In 2014
September,Sinocare acquired Beijing Jianheng Diabetes Hospital,to
step into health service area. In January of 2016, Sinocare
acquired Nipro diagnostic Inc. (now renamed as Trividia Health
Inc.), the world's sixth BGM enterprise, and reached the
international leading BGM corporation, In July of 2016, completed
acquisition of PTS Diagnostics, expand the POCT testing business,
to provide a more comprehensive solution for chronic disease
prevention.